Aden Pharmaceuticals

Vadodara, India Founded: 2006 • Age: 20 yrs
Specializes in manufacturing APIs and pharmaceutical intermediates for the healthcare industry.

About Aden Pharmaceuticals

Aden Pharmaceuticals is a Healthcare company based in Vadodara (India) founded in 2006. It specializes in manufacturing APIs and pharmaceutical intermediates for the healthcare industry. It operates on a B2B model. The company has 31 employees. Its Indian entity Aden Pharmaceuticals Private Limited reported revenue of β‚Ή13.86 Cr. Its focus areas include Pharmaceuticals, Manufacturing and APIs and Intermediates. Similar companies include Laurus Labs, Symbiotec and SeQuent; 2 of its 3 listed similar companies have raised funding.

Company details

Aden Pharmaceuticals, established in 2006, excels in providing healthcare solutions, producing pharmaceutical products, producing manufactured goods, and apis and intermediates. Specializes in manufacturing APIs and pharmaceutical intermediates for the healthcare industry. Committed to advancing standards, it focuses on innovation, efficiency, and delivering value to clients worldwide.

Key Metrics
  • Annual Revenue
    ₹13.86 Cr

    FY 2025 · +6% YoY

  • Net Loss
    -₹20.3 Lakh

    FY 2025 · -1% margin

  • EBITDA
    ₹70.9 Lakh

    FY 2025 · 5% margin

  • Employee Count
    31

Board of directors of Aden Pharmaceuticals Private Limited (Aden Pharmaceuticals)

Aden Pharmaceuticals Private Limited is the primary company behind Aden Pharmaceuticals. The board of Aden Pharmaceuticals Private Limited currently have 3 directors; the longest-serving is Ashokbhai Gobarbhai Savalia, appointed in 2006. 4 earlier directors have ceased.

DirectorDesignationAppointedTenureEntity
Ashokbhai Gobarbhai Savalia
DIN 01941679
Director28 Aug 200620 yrs 2 moAden Pharmaceuticals Private Limited
Dilipkumar Shambhubhai Dholaria
DIN 01941748
Director28 Aug 200620 yrs 2 moAden Pharmaceuticals Private Limited
Hasmukhbhai Madhabahi Antala
DIN 01941723
Director03 Jan 200818 yrs 9 moAden Pharmaceuticals Private Limited

Financials of Aden Pharmaceuticals

Figures of Aden Pharmaceuticals Private Limited, the primary company behind Aden Pharmaceuticals, for FY 2025. Revenue was ₹13.86 Cr (+6% year on year). Net loss was -₹20.3 Lakh (-1% margin). EBITDA was ₹70.9 Lakh (5% margin). Revenue has grown at a compounded annual rate of -6% over three years and -2% over five years.

  • ₹13.86 CrRevenue · FY 2025 · +6% YoY
  • -₹20.3 LakhNet loss · -1% margin
  • ₹70.9 LakhEBITDA · 5% margin
  • ₹20 LakhPaid-up capital
  • 31Employees (provident fund records)
  • -6%Revenue CAGR, 3 years
  • -2%Revenue CAGR, 5 years

Balance sheet, profit and loss, cash flow and ratios of Aden Pharmaceuticals Private Limited are on its company page.

Premium access

Detailed financial statements for Aden Pharmaceuticals

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Similar companies to Aden Pharmaceuticals

Aden Pharmaceuticals has 3 listed similar companies in our database, 2 of them funded. They include Laurus Labs, Symbiotec and SeQuent.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
lauruslabs.com2005Hyderabad, India$229.73M6,035
Pharmaceutical and biotechnology company
symbiotec.in2002Indore, India$61.01M1,822
Non-sterile steroid hormone-based APIs and intermediates are manufactured.
sequent.in2002Bengaluru, India
APIs are developed and manufactured for therapeutic areas.
Premium access

Detailed similar companies of Aden Pharmaceuticals

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Aden Pharmaceuticals

Aden Pharmaceuticals was founded in 2006.

Aden Pharmaceuticals is headquartered in Vadodara, India. It is registered at Vadodara, Gujarat, India.

Aden Pharmaceuticals has 31 employees.

The primary company behind Aden Pharmaceuticals, Aden Pharmaceuticals Private Limited, reported revenue of β‚Ή13.86 Cr for FY 2025, up 6% year on year.

Aden Pharmaceuticals, established in 2006, excels in providing healthcare solutions, producing pharmaceutical products, producing manufactured goods, and apis and intermediates. Specializes in manufacturing APIs and pharmaceutical intermediates for the healthcare industry. Committed to advancing standards, it focuses on innovation, efficiency, and delivering value to clients worldwide.

Aden Pharmaceuticals's top competitors include Laurus Labs, Symbiotec and SeQuent.

Aden Pharmaceuticals operates through Aden Pharmaceuticals Private Limited.

The legal entities of Aden Pharmaceuticals currently have 3 directors, including Hasmukhbhai Madhabahi Antala, Ashokbhai Gobarbhai Savalia, Dilipkumar Shambhubhai Dholaria.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available